Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Santarus, Inc. (NASDAQ:SNTS) 15 1 14
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) 9 0 0
Sarepta Therapeutics Inc (NASDAQ:SRPT) 19 0 1
ImmunoGen, Inc. (NASDAQ:IMGN) 5 0 2
Acorda Therapeutics Inc (NASDAQ:ACOR) 10 0 7

With the results demonstrated by our research, retail investors should always keep an eye on hedge fund and insider trading sentiment, and Nektar Therapeutics (NASDAQ:NKTR) shareholders fit into this picture quite nicely.

Click here to learn why you should track hedge funds

Page 2 of 2